Literature DB >> 10393700

Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release.

K Hostens1, D Pavlovic, Y Zambre, Z Ling, C Van Schravendijk, D L Eizirik, D G Pipeleers.   

Abstract

Infiltration of immunocytes into pancreatic islets precedes loss of beta cells in type 1 diabetes. It is conceivable that local release of cytokines affects the function of beta cells before their apoptosis. This study examines whether the elevated proinsulin levels that have been described in prediabetes can result from exposure of beta cells to cytokines. Human beta-cell preparations were cultured for 48 or 72 hours with or without IL-1beta, TNF-alpha, or IFN-gamma, alone or in combination. None of these conditions were cytotoxic, nor did they reduce insulin biosynthetic activity. Single cytokines did not alter medium or cellular content in insulin or proinsulin. Cytokine combinations, in particular IL-1beta plus IFN-gamma, disproportionately elevated medium proinsulin levels. This effect expresses an altered functional state of the beta cells characterized by preserved proinsulin synthesis, a slower hormone conversion, and an increased ratio of cellular proinsulin over insulin content. The delay in proinsulin conversion can be attributed to lower expression of PC1 and PC2 convertases. It is concluded that disproportionately elevated proinsulin levels in pre-type 1 diabetic patients might result from exposure of their beta cells to cytokines released from infiltrating immunocytes. This hormonal alteration expresses an altered functional state of the beta cells that can occur independently of beta-cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393700      PMCID: PMC408405          DOI: 10.1172/JCI6438

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity.

Authors:  R Kiekens; P In 't Veld; T Mahler; F Schuit; M Van De Winkel; D Pipeleers
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism.

Authors:  C Southern; D Schulster; I C Green
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

3.  Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.

Authors:  B Keymeulen; Z Ling; F K Gorus; G Delvaux; L Bouwens; A Grupping; C Hendrieckx; M Pipeleers-Marichal; C Van Schravendijk; K Salmela; D G Pipeleers
Journal:  Diabetologia       Date:  1998-04       Impact factor: 10.122

4.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

5.  Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat.

Authors:  Z Jiang; B A Woda
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

6.  Interplay of nutrients and hormones in the regulation of insulin release.

Authors:  D G Pipeleers; F C Schuit; P A in't Veld; E Maes; E L Hooghe-Peters; M Van de Winkel; W Gepts
Journal:  Endocrinology       Date:  1985-09       Impact factor: 4.736

7.  Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients.

Authors:  D A Heaton; B A Millward; I P Gray; Y Tun; C N Hales; D A Pyke; R D Leslie
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

8.  Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus.

Authors:  A K Foulis; M A Farquharson; A Meager
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321

9.  Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells.

Authors:  A K Foulis; M McGill; M A Farquharson
Journal:  J Pathol       Date:  1991-10       Impact factor: 7.996

10.  Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity.

Authors:  S G Hartling; F Lindgren; G Dahlqvist; B Persson; C Binder
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

View more
  35 in total

1.  Effects of metformin on oxidative stress, adenine nucleotides balance, and glucose-induced insulin release impaired by chronic free fatty acids exposure in rat pancreatic islets.

Authors:  S Piro; A M Rabuazzo; M Renis; F Purrello
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

2.  Abnormalities in proinsulin processing in islets from individuals with longstanding T1D.

Authors:  Emily K Sims; Farooq Syed; Julius Nyalwidhe; Henry T Bahnson; Leena Haataja; Cate Speake; Margaret A Morris; Appakalai N Balamurugan; Raghavendra G Mirmira; Jerry Nadler; Teresa L Mastracci; Peter Arvan; Carla J Greenbaum; Carmella Evans-Molina
Journal:  Transl Res       Date:  2019-08-09       Impact factor: 7.012

Review 3.  Islet inflammation in type 2 diabetes.

Authors:  Piero Marchetti
Journal:  Diabetologia       Date:  2016-02-19       Impact factor: 10.122

4.  Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes.

Authors:  Renecia A Watkins; Carmella Evans-Molina; Jennifer K Terrell; Kathleen H Day; Lynette Guindon; Ivan A Restrepo; Raghavendra G Mirmira; Janice S Blum; Linda A DiMeglio
Journal:  Transl Res       Date:  2015-09-04       Impact factor: 7.012

5.  Characterization of membrane-shed microvesicles from cytokine-stimulated β-cells using proteomics strategies.

Authors:  Giuseppe Palmisano; Søren Skov Jensen; Marie-Catherine Le Bihan; Jeanne Lainé; James N McGuire; Flemming Pociot; Martin Røssel Larsen
Journal:  Mol Cell Proteomics       Date:  2012-02-19       Impact factor: 5.911

6.  Serum cytokine dependent hematopoietic cell linker (CLNK) as a predictor for the duration of illness in type 2 diabetes mellitus.

Authors:  Suhaer Zeki Al-Fadhel; Nibras H Abdulsada Al-Ghuraibawi; Dunia M Mohammed Ali; Hussein Kadhem Al-Hakeim
Journal:  J Diabetes Metab Disord       Date:  2020-07-17

7.  Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes.

Authors:  I Truyen; P De Pauw; P N Jørgensen; C Van Schravendijk; O Ubani; K Decochez; E Vandemeulebroucke; I Weets; R Mao; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-10-07       Impact factor: 10.122

8.  p53 up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic beta-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress.

Authors:  Esteban N Gurzov; Carla M Germano; Daniel A Cunha; Fernanda Ortis; Jean-Marie Vanderwinden; Piero Marchetti; Lin Zhang; Decio L Eizirik
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

9.  IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice.

Authors:  Clara Y Westwell-Roper; Cyrus A Chehroudi; Heather C Denroche; Jaques A Courtade; Jan A Ehses; C Bruce Verchere
Journal:  Diabetologia       Date:  2014-12-10       Impact factor: 10.122

10.  Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat.

Authors:  Grégory Lacraz; Marie-Hélène Giroix; Nadim Kassis; Josiane Coulaud; Anne Galinier; Christophe Noll; Mélanie Cornut; Fabien Schmidlin; Jean-Louis Paul; Nathalie Janel; Jean-Claude Irminger; Micheline Kergoat; Bernard Portha; Marc Y Donath; Jan A Ehses; Françoise Homo-Delarche
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.